High-frequency component in flash visual evoked potentials in type 3 Gaucher disease. 2020

Masayoshi Oguri, and Yoshiaki Saito, and Tohru Okanishi, and Yuka Matuura, and Shota Akiyama, and Takuya Ikeguchi, and Aya Narita, and Yasuaki Hirooka, and Yoshihiro Maegaki
Department of Pathobiological Science and Technology, Faculty of Medicine, Tottori University, Yonago, Japan.

OBJECTIVE To characterize the visual evoked potentials (VEP) in patients with type 3 Gaucher disease (GD) with or without progressive myoclonus epilepsy. METHODS Three young adults with progressive myoclonus epilepsy (type 3a GD) and two children without progressive myoclonus epilepsy (type 3b GD) were enrolled. Flash visual and somatosensory evoked potentials (F-VEP and SEP, respectively) were retrospectively reviewed in all patients under enzyme replacement therapy. Pattern reversal visual evoked potentials (PR-VEP) were recorded in the type 3a group. RESULTS High-frequency components were provoked at early latencies on averaged F-VEP in all patients with type 3a and one patient with type 3b GD. Conversely, no activities were recorded in PR-VEP. The onset latency of the components began at 15.3-19.8 ms after flash stimulation. Four-five of the F-VEP examination the activities' duration overrode the N75 waveforms and were prolonged toward the P100 peak latency. The F-VEP amplitude did not differ between the type 3a and type 3b groups, while the SEP amplitude was higher in the type 3a than in the type 3b group. CONCLUSIONS High-frequency components on F-VEP using bandpass filter at 10-200 Hz may help assess augmented excitability in the visual cortex of type 3 GD patients.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D008297 Male Males
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D005074 Evoked Potentials, Visual The electric response evoked in the cerebral cortex by visual stimulation or stimulation of the visual pathways. Visual Evoked Response,Evoked Potential, Visual,Evoked Response, Visual,Evoked Responses, Visual,Potential, Visual Evoked,Potentials, Visual Evoked,Response, Visual Evoked,Responses, Visual Evoked,Visual Evoked Potential,Visual Evoked Potentials,Visual Evoked Responses
D005260 Female Females
D005776 Gaucher Disease An autosomal recessive disorder caused by a deficiency of acid beta-glucosidase (GLUCOSYLCERAMIDASE) leading to intralysosomal accumulation of glycosylceramide mainly in cells of the MONONUCLEAR PHAGOCYTE SYSTEM. The characteristic Gaucher cells, glycosphingolipid-filled HISTIOCYTES, displace normal cells in BONE MARROW and visceral organs causing skeletal deterioration, hepatosplenomegaly, and organ dysfunction. There are several subtypes based on the presence and severity of neurological involvement. Cerebroside Lipidosis Syndrome,Gaucher Disease Type 1,Gaucher Disease Type 2,Glucocerebrosidase Deficiency Disease,Glucosylceramide Beta-Glucosidase Deficiency Disease,Neuronopathic Gaucher Disease,Acid beta-Glucosidase Deficiency,Acid beta-Glucosidase Deficiency Disease,Acute Neuronopathic Gaucher Disease,Chronic Gaucher Disease,GBA Deficiency,Gaucher Disease Type 3,Gaucher Disease, Acute Neuronopathic,Gaucher Disease, Acute Neuronopathic Type,Gaucher Disease, Chronic,Gaucher Disease, Chronic Neuronopathic Type,Gaucher Disease, Infantile,Gaucher Disease, Infantile Cerebral,Gaucher Disease, Juvenile,Gaucher Disease, Juvenile and Adult, Cerebral,Gaucher Disease, Neuronopathic,Gaucher Disease, Non-Neuronopathic Form,Gaucher Disease, Noncerebral Juvenile,Gaucher Disease, Subacute Neuronopathic Form,Gaucher Disease, Subacute Neuronopathic Type,Gaucher Disease, Type 1,Gaucher Disease, Type 2,Gaucher Disease, Type 3,Gaucher Disease, Type I,Gaucher Disease, Type II,Gaucher Disease, Type III,Gaucher Splenomegaly,Gaucher Syndrome,Gaucher's Disease,Gauchers Disease,Glucocerebrosidase Deficiency,Glucocerebrosidosis,Glucosyl Cerebroside Lipidosis,Glucosylceramidase Deficiency,Glucosylceramide Beta-Glucosidase Deficiency,Glucosylceramide Lipidosis,Infantile Gaucher Disease,Kerasin Histiocytosis,Kerasin Lipoidosis,Kerasin thesaurismosis,Lipoid Histiocytosis (Kerasin Type),Non-Neuronopathic Gaucher Disease,Subacute Neuronopathic Gaucher Disease,Type 1 Gaucher Disease,Type 2 Gaucher Disease,Type 3 Gaucher Disease,Cerebroside Lipidoses, Glucosyl,Cerebroside Lipidosis Syndromes,Cerebroside Lipidosis, Glucosyl,Deficiencies, GBA,Deficiencies, Glucocerebrosidase,Deficiency Disease, Glucocerebrosidase,Deficiency Diseases, Glucocerebrosidase,Deficiency, GBA,Deficiency, Glucocerebrosidase,Disease, Chronic Gaucher,Disease, Gaucher,Disease, Gaucher's,Disease, Gauchers,Disease, Glucocerebrosidase Deficiency,Disease, Infantile Gaucher,Disease, Juvenile Gaucher,Disease, Neuronopathic Gaucher,Disease, Non-Neuronopathic Gaucher,Diseases, Gauchers,Diseases, Glucocerebrosidase Deficiency,GBA Deficiencies,Gaucher Disease, Non Neuronopathic Form,Gaucher Disease, Non-Neuronopathic,Gauchers Diseases,Glucocerebrosidase Deficiencies,Glucocerebrosidase Deficiency Diseases,Glucocerebrosidoses,Glucosyl Cerebroside Lipidoses,Glucosylceramide Lipidoses,Histiocytoses, Kerasin,Histiocytoses, Lipoid (Kerasin Type),Histiocytosis, Kerasin,Histiocytosis, Lipoid (Kerasin Type),Juvenile Gaucher Disease,Kerasin Histiocytoses,Kerasin Lipoidoses,Kerasin thesaurismoses,Lipidoses, Glucosyl Cerebroside,Lipidoses, Glucosylceramide,Lipidosis Syndrome, Cerebroside,Lipidosis Syndromes, Cerebroside,Lipidosis, Glucosyl Cerebroside,Lipidosis, Glucosylceramide,Lipoid Histiocytoses (Kerasin Type),Lipoidoses, Kerasin,Lipoidosis, Kerasin,Non Neuronopathic Gaucher Disease,Splenomegaly, Gaucher,Syndrome, Cerebroside Lipidosis,Syndrome, Gaucher,Syndromes, Cerebroside Lipidosis,thesaurismoses, Kerasin,thesaurismosis, Kerasin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective
D055815 Young Adult A person between 19 and 24 years of age. Adult, Young,Adults, Young,Young Adults

Related Publications

Masayoshi Oguri, and Yoshiaki Saito, and Tohru Okanishi, and Yuka Matuura, and Shota Akiyama, and Takuya Ikeguchi, and Aya Narita, and Yasuaki Hirooka, and Yoshihiro Maegaki
January 1998, Electroencephalography and clinical neurophysiology,
Masayoshi Oguri, and Yoshiaki Saito, and Tohru Okanishi, and Yuka Matuura, and Shota Akiyama, and Takuya Ikeguchi, and Aya Narita, and Yasuaki Hirooka, and Yoshihiro Maegaki
February 2001, Neurology,
Masayoshi Oguri, and Yoshiaki Saito, and Tohru Okanishi, and Yuka Matuura, and Shota Akiyama, and Takuya Ikeguchi, and Aya Narita, and Yasuaki Hirooka, and Yoshihiro Maegaki
January 1984, Developments in ophthalmology,
Masayoshi Oguri, and Yoshiaki Saito, and Tohru Okanishi, and Yuka Matuura, and Shota Akiyama, and Takuya Ikeguchi, and Aya Narita, and Yasuaki Hirooka, and Yoshihiro Maegaki
March 2013, Ophthalmology,
Masayoshi Oguri, and Yoshiaki Saito, and Tohru Okanishi, and Yuka Matuura, and Shota Akiyama, and Takuya Ikeguchi, and Aya Narita, and Yasuaki Hirooka, and Yoshihiro Maegaki
January 1998, Klinika oczna,
Masayoshi Oguri, and Yoshiaki Saito, and Tohru Okanishi, and Yuka Matuura, and Shota Akiyama, and Takuya Ikeguchi, and Aya Narita, and Yasuaki Hirooka, and Yoshihiro Maegaki
May 1983, The International journal of neuroscience,
Masayoshi Oguri, and Yoshiaki Saito, and Tohru Okanishi, and Yuka Matuura, and Shota Akiyama, and Takuya Ikeguchi, and Aya Narita, and Yasuaki Hirooka, and Yoshihiro Maegaki
April 2007, Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology,
Masayoshi Oguri, and Yoshiaki Saito, and Tohru Okanishi, and Yuka Matuura, and Shota Akiyama, and Takuya Ikeguchi, and Aya Narita, and Yasuaki Hirooka, and Yoshihiro Maegaki
September 2006, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas,
Masayoshi Oguri, and Yoshiaki Saito, and Tohru Okanishi, and Yuka Matuura, and Shota Akiyama, and Takuya Ikeguchi, and Aya Narita, and Yasuaki Hirooka, and Yoshihiro Maegaki
September 1968, Electroencephalography and clinical neurophysiology,
Masayoshi Oguri, and Yoshiaki Saito, and Tohru Okanishi, and Yuka Matuura, and Shota Akiyama, and Takuya Ikeguchi, and Aya Narita, and Yasuaki Hirooka, and Yoshihiro Maegaki
January 2004, Zhonghua yi xue za zhi,
Copied contents to your clipboard!